We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approving Novel Drugs at Same Rate Despite Pandemic; PDUFA Picture Unclear
FDA Approving Novel Drugs at Same Rate Despite Pandemic; PDUFA Picture Unclear
The COVID-19 pandemic does not appear to be slowing down the rate at which the FDA is approving novel drugs, although there is anecdotal evidence that it is causing the agency to miss some deadlines for approvals under the Prescription Drug User Fee Act (PDUFA).